| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MT2A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | TSC22D4 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | SMAD5 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | TIGD4 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | C16orf46 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BMF | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | SDHC | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | UBAP2L | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | HARS2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
